IPP Bureau
Nobel prize 2023 for medicine awarded to Katalin Karikó, Drew Weissman for research on mRNA vaccines to fight Covid-19
By IPP Bureau - October 03, 2023
The discoveries by the two Nobel Laureates were critical for developing effective mRNA vaccines against COVID-19
Briefs: Aurobindo Pharma and Balaxi Pharmaceuticals
By IPP Bureau - October 03, 2023
Balaxi Healthcare Ecuador S.A.S. has become a Wholly Owned Subsidiary of the company
Solvay celebrates Medicine Nobel Prize winner Katalin Karikó
By IPP Bureau - October 03, 2023
Dr. Karikó is the third Solvay Prize winner to become a Nobel Prize laureate
SigTuple’s AI100 with Shonit receives USFDA 510(k) clearance
By IPP Bureau - October 03, 2023
SigTuple’s AI100 with Shonit is the premier solution for AI assisted digital pathology
Solvay launches new PVDC coating solution for more sustainable pharma blister films
By IPP Bureau - October 03, 2023
Diofan Ultra736 provides ultra-high water vapor barrier with excellent thermoformability, unlocking the potential to design thinner and more sustainable blister films
Advent International announces the completion of the acquision of Suven Pharma
By IPP Bureau - September 30, 2023
New Board of Directors and management team at Suven Pharma also appointed
Menarini strengthens its presence in aesthetic dermatology in India
By IPP Bureau - September 30, 2023
The introduction of 'Definisse Core Filler' is a testament to the company's premium scientific-based innovation
Lupin Receives EIR from U.S. FDA for its Nagpur Unit-1 manufacturing facility
By IPP Bureau - September 30, 2023
The U.S. FDA has determined that the inspection classification of the facility is Voluntary Action Indicated
Apollo Hospitals celebrates its leadership position as the largest Cardiac care programme in India
By IPP Bureau - September 29, 2023
Apollo's unparalleled clinical excellence is built on extensive experience of performing over 300,000 angioplasties and 200,000 cardiac surgeries
USFDA delegation visits Divi's Laboratories’ Unit I at Choutuppal, Telangana
By IPP Bureau - September 29, 2023
The delegation's visit covered a wide range of topics
Berhyanda gets nod for acquisition of up to 76.1% stake in Suven Pharmaceuticals
By IPP Bureau - September 29, 2023
The aggregate foreign investment, including investment from other foreign investors may be up to 90.1% shareholding in the company
Doceree raises US$ 35 million in Series B Funding
By IPP Bureau - September 29, 2023
Capital raise to accelerate product and technology development and support expansion efforts to reshape communications to HCPs across the globe
Lupin's Joint Airways Initiative surpasses 10,000 patients
By IPP Bureau - September 29, 2023
USFDA inspection at Piramal Pharma’s Bethlehem facility
By IPP Bureau - September 29, 2023
Briefs: Sun Pharmaceutical Industries and Dr. Reddy’s
By IPP Bureau - September 29, 2023
Post-acquisition of the balance 25% outstanding shares will result into Sun Pharma de México, S.A. de C.V. becoming a wholly-owned subsidiary of the company.
